These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 9023263)
41. The brain-to-blood efflux transport of taurine and changes in the blood-brain barrier transport system by tumor necrosis factor-alpha. Lee NY; Kang YS Brain Res; 2004 Oct; 1023(1):141-7. PubMed ID: 15364029 [TBL] [Abstract][Full Text] [Related]
42. Zidovudine transport within the rabbit brain during intracerebroventricular administration and the effect of probenecid. Wang Y; Wei Y; Sawchuk RJ J Pharm Sci; 1997 Dec; 86(12):1484-90. PubMed ID: 9423165 [TBL] [Abstract][Full Text] [Related]
43. Blood-brain barrier transport helps to explain discrepancies in in vivo potency between oxycodone and morphine. Boström E; Hammarlund-Udenaes M; Simonsson US Anesthesiology; 2008 Mar; 108(3):495-505. PubMed ID: 18292687 [TBL] [Abstract][Full Text] [Related]
44. Ventriculo-cisternal perfusion of twelve amino acids in the rabbit. Davson H; Hollingsworth JG; Carey MB; Fenstermacher JD J Neurobiol; 1982 Jul; 13(4):293-318. PubMed ID: 7108514 [TBL] [Abstract][Full Text] [Related]
45. P-glycoprotein efflux at the blood-brain barrier mediates differences in brain disposition and pharmacodynamics between two structurally related neurokinin-1 receptor antagonists. Smith BJ; Doran AC; McLean S; Tingley FD; O'Neill BT; Kajiji SM J Pharmacol Exp Ther; 2001 Sep; 298(3):1252-9. PubMed ID: 11504828 [TBL] [Abstract][Full Text] [Related]
46. Comparative distribution of quinolone antibiotics in cerebrospinal fluid and brain in rats and dogs. Ooie T; Suzuki H; Terasaki T; Sugiyama Y J Pharmacol Exp Ther; 1996 Aug; 278(2):590-6. PubMed ID: 8768708 [TBL] [Abstract][Full Text] [Related]
47. Transport of prostaglandin E1 across the blood-brain barrier in rats. Taogoshi T; Nomura A; Murakami T; Nagai J; Takano M J Pharm Pharmacol; 2005 Jan; 57(1):61-6. PubMed ID: 15638994 [TBL] [Abstract][Full Text] [Related]
48. Interactions between cimetidine, nitrofurantoin, and probenecid active transport into rat milk. Gerk PM; Oo CY; Paxton EW; Moscow JA; McNamara PJ J Pharmacol Exp Ther; 2001 Jan; 296(1):175-80. PubMed ID: 11123378 [TBL] [Abstract][Full Text] [Related]
49. GHB (gamma-hydroxybutyrate) carrier-mediated transport across the blood-brain barrier. Bhattacharya I; Boje KM J Pharmacol Exp Ther; 2004 Oct; 311(1):92-8. PubMed ID: 15173314 [TBL] [Abstract][Full Text] [Related]
50. Transport of imipenem, a novel carbapenem antibiotic, in the rat central nervous system. Suzuki H; Sawada Y; Sugiyama Y; Iga T; Hanano M; Spector R J Pharmacol Exp Ther; 1989 Sep; 250(3):979-84. PubMed ID: 2506338 [TBL] [Abstract][Full Text] [Related]
51. Nonlinear disposition kinetics of a novel antifolate, MX-68, in rats. Han YH; Kato Y; Sugiyama Y J Pharmacol Exp Ther; 1999 Oct; 291(1):204-12. PubMed ID: 10490906 [TBL] [Abstract][Full Text] [Related]
52. Neuropharmacokinetics of a new alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) modulator, S18986 [(S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide], in the rat. Bourasset F; Bernard K; Muñoz C; Genissel P; Scherrmann JM Drug Metab Dispos; 2005 Aug; 33(8):1137-43. PubMed ID: 15860654 [TBL] [Abstract][Full Text] [Related]
53. Brain efflux index as a novel method of analyzing efflux transport at the blood-brain barrier. Kakee A; Terasaki T; Sugiyama Y J Pharmacol Exp Ther; 1996 Jun; 277(3):1550-9. PubMed ID: 8667222 [TBL] [Abstract][Full Text] [Related]
54. Utility of cerebrospinal fluid drug concentration as a surrogate for unbound brain concentration in nonhuman primates. Nagaya Y; Nozaki Y; Kobayashi K; Takenaka O; Nakatani Y; Kusano K; Yoshimura T; Kusuhara H Drug Metab Pharmacokinet; 2014; 29(5):419-26. PubMed ID: 24806821 [TBL] [Abstract][Full Text] [Related]
55. Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentration. Liu X; Smith BJ; Chen C; Callegari E; Becker SL; Chen X; Cianfrogna J; Doran AC; Doran SD; Gibbs JP; Hosea N; Liu J; Nelson FR; Szewc MA; Van Deusen J Drug Metab Dispos; 2006 Sep; 34(9):1443-7. PubMed ID: 16760229 [TBL] [Abstract][Full Text] [Related]
56. Carrier-mediated uptake of H2-receptor antagonists by the rat choroid plexus: involvement of rat organic anion transporter 3. Nagata Y; Kusuhara H; Hirono S; Endou H; Sugiyama Y Drug Metab Dispos; 2004 Sep; 32(9):1040-7. PubMed ID: 15319347 [TBL] [Abstract][Full Text] [Related]
57. Effect of probenecid and quinidine on the transport of alovudine (3'-fluorothymidine) to the rat brain studied by microdialysis. Lindén K; Ståhle L; Ljungdahl-Ståhle E; Borg N Pharmacol Toxicol; 2003 Nov; 93(5):226-32. PubMed ID: 14629734 [TBL] [Abstract][Full Text] [Related]
58. Carrier-mediated processes at several rat brain interfaces determine the neuropharmacokinetics of morphine and morphine-6-beta-D-glucuronide. Bourasset F; Scherrmann JM Life Sci; 2006 Apr; 78(20):2302-14. PubMed ID: 16309712 [TBL] [Abstract][Full Text] [Related]
59. An evaluation of using rat-derived single-dose neuropharmacokinetic parameters to project accurately large animal unbound brain drug concentrations. Doran AC; Osgood SM; Mancuso JY; Shaffer CL Drug Metab Dispos; 2012 Nov; 40(11):2162-73. PubMed ID: 22899853 [TBL] [Abstract][Full Text] [Related]
60. Microdialysis study of zidovudine (AZT) transport in rat brain. Dykstra KH; Arya A; Arriola DM; Bungay PM; Morrison PF; Dedrick RL J Pharmacol Exp Ther; 1993 Dec; 267(3):1227-36. PubMed ID: 8263784 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]